Abstract
Cancer has recently surpassed heart disease as the number one killer of Americans younger than 85 (1). Although prostate and breast cancers are the most common, lung cancer continues as the top killer among cancers because of its relatively poor prognosis (2). Improved survival across most cancer types is the result of progress in cancer prevention, early detection, and better treatment (3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106–130.
Kuzniar T, Masters GA, Ray DW. Screening for lung cancer—a review. Med Sci Monit 2004;10:RA21–30.
Stewart SL, King JB, Thompson TD, Friedman C, Wingo PA. Cancer mortality surveillance-United States, 1990–2000. MMWR Surveill Summ 2004;53:l–108.
Patchell RA, Posner JB. Neurologic complications of systemic cancer. Neurol Clin 1985;3: 729–749.
Plotkin SR, Wen PY. Neurologie complications of cancer therapy. Neurol Clin 2003;21:279–318.
Falah M, Schiff D, Burns TM. Neuromuscular complications of cancer diagnosis and treatment. J Support Oncol 2005;3:271–282.
Royal MA. The use of botulinum toxins in the management of pain and headache. Phys Med Rehabil Clin N Am 2003; 14:805–820.
Okereke LI, Stubblefield MD, Custodio CM. Botulinum toxin type A for radiation-induced trismus and facial pain: a case report. Arch Phys Med Rehabil 2004;85:E37.
Chou WW, Puri DR, Lee NY. Intensity-modulated radiation therapy for head and neck cancer. Expert Rev Anticancer Ther 2005;5:515–521.
Saarto T, Janes R, Tenhunen, Kouri M. Palliate radiotherapy in the treatment of skeletal metastases. Eur J Pain 2002;6:323–330.
Chow E, Wu J, Loblaw A, Perez CA. Radiotherapeutic approaches to metastatic disease. World J Urol 2003;21:229–242.
O’Meara WP, Lee N. Advances in nasopharyngeal carcinoma. Curr Opin Oncol 2005;17:225–230.
Tannock IF. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 1989;16:83–101.
Hauer-Jensen M, Fink LM, Wang J. Radiation injury and the protein C pathway. Crit Care Med 2004;32:S325–S330.
Libshitz HI, DuBrow RA, Loyer EM, Charnsangavej C. Radiation change in normal organs: an overview of body imaging. Eur. Radiol 1996;6:786–795. 37
Portlock CS, Boland P, Hays AP, Antonescu CR, Rosenblum MK. Nemaline myopathy: a possible late complication of Hodgkin’s disease therapy. Hum Pathol 2003;34:816–818.
Johansson S, Svensson H, Larsson L, Denekamp J. Brachial plexopathy after postoperative radiotherapy of breast cancer patients: a long-term follow-up. Acta Oncologica 2000;39:373–382.
New P. Radiation injury to the nervous system. Curr Opin Neurol 2001; 14:725–734.
Johansson S, Svensson H, Denekamp J. Dose response and the latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiation Oncology Biol Phys 2002;52:1207–1219.
Johansson S, Svensson H, Denekamp J. Timescale of evolution of late radiation injury after posoperative radiotherapy of breast cancer patients. Int J Radiation Oncol Biol Phys 2000; 48:745–750.
Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2004;4:529–536.
Lund MD, Kongerud J, Boe J, et al. [Late complications after treatment of Hodgkin’s disease] [Article in Norwegian]. Tidsskr Nor Laegeforen 1999;10:933–937.
Falkmer U, Järhult J, Wersäll P, Cavallin-Ståhl. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncologica 2003;42:620–633.
Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiation Oncology Biol Phys 2004;60:265–274.
Cross NE, Glantz MJ. Neurologic complications of radiation therapy. Neurol Clin N Am 2003;21:249–277.
Gillette EL, Mahler PA, Powers BE, Gillette SM, Vujaskovic Z. Late radiation injury to muscle and peripheral nerves. Int J Radiation Oncology Biol Phys 1995;31:1309–1318.
Greenfield MM, Stark GM. Post-irradiation neuropathy. AJR Am J Roentgenol 1948;60: 617–622.
Miller TM, Layzer RB. Muscle cramps. Muscle Nerve 2005;32:431–442.
Karuman PN, Soo KC. Motor innervation of the trapezius muscle: a histochemical study. 1996; 18:254–258.
Stubblefield MD, Custodio CM. Upper-extremity pain disorders in breast cancer. Arch Phys Med Rehabil 2006;87:S96–S99.
Jaeckle KA. Neurological manifestations of neoplastic and radiation-induced plexopathies. Semin in Neurol 2004;24:385–393.
Tytherleigh-Strong G, Hirahara A, Miniaci A. Rotator cuff disease. Curr Opin Rheumatol 2001;13:135–145.
Welch MJ, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root ganglia neurons to clostridium botulinum neurotoxins. Toxicon 2000;38:245–258.
Durham PL, Cady R, Cady RK. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 2004;44:35–42.
Cui M, Li Z, You S, Khanijou S, Aoki KR. Mechanisms of the anti-nociceptive effect of subcutaneous Botox®: inhibition of peripheral and central nociceptive processing. Naunyn Schmiedebergs Arch Pharmacol 2002;365:R17.
Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 2005;26:785–793.
Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004;107:125–133.
Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncologica 2003;42:443–461.
Jung H, Beck-Bornholdt H, Svoboda V, Alberti W, Herrmann T. Quantification of late complications after radiation therapy. Radiother Oncol 2001;61:233–246.
Lou JS, Pleninger P, Kurlan R. Botulinu toxin A is effective in treating trismus associated with postradiation myokymia and muscle spasm. Mov Disord 1995;10:680–681. 38
Dijkstra PU, Kalk WWI, Roodenburg JLN. Trismus in head and neck oncology: a systematic review. Oral Oncol 2004;40:879–889.
Piovesan EJ, Teive HG, Kowacs PA, Delia Coletta MV, Werneck LC, Silberstein SD. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 2005;65:1306–1308.
O’Brien CF. Treatment of spasticity with botulinum toxin. Clin J Pain 2002;18:S182–S190.
Shneker BF, McAuley JW. Pregabalin: a new neuromodulator with broad therapeutic indications. Ann Pharmacother 2005;39:2029–2037.
Fine PG, Miaskowski C, Paice JA. Meeting the challenges in cancer pain management. J Support Oncol 2004;2:5–22.
Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005;118:289–305.
Cohen EG, Deschler DG, Walsh K, Hayden RE. Early use of a mechanical stretching device to improve mandibular mobility after composite resection: a pilot study. Arch Phys Med Rehabil 2005;86:1416–1419.
Astudillo L, Hollington L, Game X, et al. Cervical dystonia mimicking dropped-head syndrome after radiotherapy for laryngeal carcinoma. Clin Neurol Neurosurg 2003;106:41–43.
Costa J, Espirito-Santo C, Borges A, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 2005;25:CD003633.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this chapter
Cite this chapter
Stubblefield, M.D. (2007). Radiation Fibrosis Syndrome. In: Cooper, G. (eds) Therapeutic Uses of Botulinum Toxin. Humana Press. https://doi.org/10.1007/978-1-59745-247-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-59745-247-2_3
Publisher Name: Humana Press
Print ISBN: 978-1-58829-914-7
Online ISBN: 978-1-59745-247-2
eBook Packages: MedicineMedicine (R0)